434 related articles for article (PubMed ID: 23215800)
21. Analysis of rare thalassemia caused by HS-40 regulatory site deletion.
Luo S; Chen X; Zhong Q; Wang Q; Xu Z; Qin L; Wang J; Yuan D; Yan T; Tang N
Hematology; 2020 Dec; 25(1):286-291. PubMed ID: 32720864
[No Abstract] [Full Text] [Related]
22. Unmasking Hb Paksé (codon 142, TAA>TAT, α2) and its combinations in patients also carrying Hb Constant Spring (codon 142, TAA>CAA, α2) in northern Thailand.
Pornprasert S; Panyasai S; Treesuwan K
Hemoglobin; 2012; 36(5):491-6. PubMed ID: 22881835
[TBL] [Abstract][Full Text] [Related]
23. Hemoglobin Lepore EF Bart's disease: a molecular, hematological, and diagnostic aspects.
Chaibunruang A; Fucharoen G; Jetsrisuparb A; Fucharoen S
Ann Hematol; 2011 Nov; 90(11):1337-40. PubMed ID: 21302111
[TBL] [Abstract][Full Text] [Related]
24. Identification of α-globin chain variants: a report from Iran.
Akbari MT; Hamid M
Arch Iran Med; 2012 Sep; 15(9):564-7. PubMed ID: 22924376
[TBL] [Abstract][Full Text] [Related]
25. Thalassemia intermedia associated with complex interaction of Hb Beijing [alpha16(A14)Lys-->Asn] and Hb E [beta26(B8)Glu-->Lys] with a deletional alpha-thalassemia-1 in a Thai family.
Fucharoen S; Chunpanich S; Sanchaisuriya K; Fucharoen G; Kunyanone N
Hemoglobin; 2005; 29(1):77-83. PubMed ID: 15768559
[TBL] [Abstract][Full Text] [Related]
26. Clinical phenotypes and molecular characterization of Hb H-Paksé disease.
Viprakasit V; Tanphaichitr VS; Pung-Amritt P; Petrarat S; Suwantol L; Fisher C; Higgs DR
Haematologica; 2002 Feb; 87(2):117-25. PubMed ID: 11836160
[TBL] [Abstract][Full Text] [Related]
27. A rare Hb H disease due to the - -(SEA) and 16.6 kb α-thalassemia-2 deletions.
Sroymora S; Jindadamrongwech S; Butthep P; Chuncharunee S
Hemoglobin; 2012; 36(2):200-4. PubMed ID: 22376301
[TBL] [Abstract][Full Text] [Related]
28. Molecular and clinical features of Hb H disease in northern Thailand.
Charoenkwan P; Taweephon R; Sae-Tung R; Thanarattanakorn P; Sanguansermsri T
Hemoglobin; 2005; 29(2):133-40. PubMed ID: 15921165
[TBL] [Abstract][Full Text] [Related]
29. α-Thalassemia Intermedia Results from Interactions of Unstable Hb Prato [α31(B12)Arg→Ser (
Panyasai S; Phasit A
Hemoglobin; 2020 Jul; 44(4):264-271. PubMed ID: 32727229
[TBL] [Abstract][Full Text] [Related]
30. Hemoglobin profile and molecular characteristics of the complex interaction of hemoglobin Doi-Saket [α9(A7) asn > lys, HBA2:c.30C > a], a novel α2α1 hybrid globin variant, with hemoglobin E [β26(B8) Glu > lys, HBB:c.79G > A] and deletional α
Panyasai S; Khongthai K; Satthakarn S
Ann Med; 2023; 55(2):2264174. PubMed ID: 37796611
[TBL] [Abstract][Full Text] [Related]
31. The correlation of α-globin gene mutations and the XmnI polymorphism with clinical severity of Hb E/β-thalassemia.
Charoenkwan P; Teerachaimahit P; Sanguansermsri T
Hemoglobin; 2014; 38(5):335-8. PubMed ID: 25238043
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic expression of Hb F in common high Hb F determinants in Thailand: roles of α-thalassemia, 5' δ-globin BCL11A binding region and 3' β-globin enhancer.
Prakobkaew N; Fucharoen S; Fuchareon G; Siriratmanawong N
Eur J Haematol; 2014 Jan; 92(1):73-9. PubMed ID: 24112054
[TBL] [Abstract][Full Text] [Related]
33. Prevention of Hb Bart's (γ4) Disease Associated with the - -(THAI) α(0)-Thalassemia Deletion in Mainland China.
Li DZ; Li Y; Li J; Li SC; Li R
Hemoglobin; 2015; 39(6):412-4. PubMed ID: 26212676
[TBL] [Abstract][Full Text] [Related]
34. Hematological characterization of compound heterozygous hemoglobin Hope/E patients with and without alpha-thalassemia-1 SEA type deletion.
Pornprasert S
Clin Lab; 2013; 59(9-10):1183-5. PubMed ID: 24273946
[TBL] [Abstract][Full Text] [Related]
35. Complex Interaction of Hb Q-Thailand with α
He S; Qin Q; Lin L; Chen Q; Yi S; Wei H; Du J; Zheng C; Qiu X; Chen B
Hemoglobin; 2017 Jan; 41(1):68-72. PubMed ID: 28475397
[TBL] [Abstract][Full Text] [Related]
36. Hb Constant Spring [alpha 142, Term-->Gln (TAA>CAA in alpha2)] in the alpha-thalassemia of anemic patients in Myanmar.
Ne-Win ; Harano K; Harano T; Kyaw-Shwe ; Aye-Aye-Myint ; Khin-Thander-Aye ; Okada S
Hemoglobin; 2008; 32(5):454-61. PubMed ID: 18932070
[TBL] [Abstract][Full Text] [Related]
37. Molecular and hematological characteristics of a novel form of α-globin gene triplication: the hemoglobin St.Luke's-Thailand [α95(G2)Pro→Arg] or Hb St. Luke's [A2] HBA2.
Singha K; Fucharoen G; Jetsrisuparb A; Fucharoen S
Clin Biochem; 2013 May; 46(7-8):675-80. PubMed ID: 23395770
[TBL] [Abstract][Full Text] [Related]
38. Hemoglobin Pyrgos with hemoglobin H disease: new triple heterozygosity.
Insiripong S; Jitpakdeebodin V; Jopang Y; Fucharoen S
Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1258-61. PubMed ID: 23431835
[TBL] [Abstract][Full Text] [Related]
39. Complex interaction of Hb Hekinan [alpha27(B8) Glu-Asp] and Hb E [beta26(B8) Glu-Lys] with a deletional alpha-thalassemia 1 in a Thai family.
Fucharoen S; Changtrakun Y; Ratanasiri T; Fucharoen G; Sanchaisuriya K
Eur J Haematol; 2003 May; 70(5):304-9. PubMed ID: 12694166
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Alpha-Thalassemia Mutations in Cases with Hypochromic Microcytic Anemia: The İstanbul Perspective.
Karakaş Z; Koç B; Temurhan S; Elgün T; Karaman S; Asker G; Gençay G; Timur Ç; Yıldırmak ZY; Celkan T; Devecioğlu Ö; Aydın F
Turk J Haematol; 2015 Dec; 32(4):344-50. PubMed ID: 26377141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
